Arbovax preparing for dengue fever vaccine clinical trials
Vaccine developer Arbovax has raised $1.7 million in a Series A round of financing that the company is using to prepare for clinical trials on a dengue fever vaccine candidate. Raleigh, North Carolina-based Arbovax has a platform vaccine technology that the company is developing to address insect-borne diseases. While the tropical disease dengue fever is […]